503A vs 503B compounding pharmacy — regulatory framework and verification checklist for compounded GLP-1 medications

503A vs 503B Compounding Pharmacy vs PlexusDx (2026): What Patients Actually Need to Know | PlexusDx

503A vs 503B compounding pharmacy explained — the regulatory framework, FDA Modernization Act of 1997 and Drug Quality and Security Act of 2013, oversight differences, and a five-step verification checklist for compounded GLP-1 medications.